S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ACST Acasti Pharma Inc

3.37

0.00 (0.00%)

Feb 13 2025 - Closed

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Acasti Pharma (NASDAQ:ACST)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Acasti Pharma Charts.

Acasti Pharma (NASDAQ:ACST)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Acasti Pharma Charts.

Acasti Pharma Inc News

Form 8-K - Current report
Monday 28 October 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 25 October 2024 (4 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Tuesday 15 October 2024 (4 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 8 October 2024 (4 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Tuesday 8 October 2024 (4 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Tuesday 8 October 2024 (4 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Tuesday 8 October 2024 (4 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Tuesday 8 October 2024 (4 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Tuesday 8 October 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 30 September 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 25 September 2024 (5 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Friday 6 September 2024 (5 months ago) • Edgar (US Regulatory)

More Acasti Pharma Inc News Articles

Elite Pharmaceuticals (QB)

Innovation Pharmaceuticals (CE)

Fannie Mae (QB)

North Bay Resources (PK)

Northwest Biotherapeutics (QB)

Lightwave Logic

Anavex Life Sciences

Rennova Health (CE)

Good Vibrations Shoes (PK)

Kraig Biocraft Laborator... (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions